Pretty cool, but they've achieved CRs in AML before (and so have many other drugs being trialed by other companies), so not earth shattering news.
Sadly, only 3 of 12 patients enrolled so far. Another trial of CHM assets progressing at a snails pace.
Ann: AML patient achieves Complete Response in CHM CORE-NK trial, page-4
Add to My Watchlist
What is My Watchlist?
